SHOCKWAVE MED INC's ticker is SWAV and the CUSIP is 82489T104. A total of 222 filers reported holding SHOCKWAVE MED INC in Q4 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $757,541 | -24.1% | 3,805 | +8.8% | 0.03% | -23.7% |
| Q2 2023 | $998,041 | -2.6% | 3,497 | -26.0% | 0.04% | -9.5% |
| Q1 2023 | $1,024,482 | +4.2% | 4,725 | -1.2% | 0.04% | -14.3% |
| Q4 2022 | $982,816 | -24.1% | 4,780 | +2.6% | 0.05% | -27.9% |
| Q3 2022 | $1,295,000 | -17.7% | 4,658 | -43.4% | 0.07% | -15.0% |
| Q2 2022 | $1,573,000 | -8.2% | 8,230 | -0.4% | 0.08% | +11.1% |
| Q1 2022 | $1,714,000 | +13.5% | 8,264 | -2.4% | 0.07% | +10.8% |
| Q4 2021 | $1,510,000 | +19.8% | 8,466 | +38.4% | 0.06% | +3.2% |
| Q3 2021 | $1,260,000 | +26.9% | 6,118 | +17.0% | 0.06% | +26.0% |
| Q2 2021 | $993,000 | +14.1% | 5,231 | -21.7% | 0.05% | -3.8% |
| Q1 2021 | $870,000 | +83.2% | 6,679 | +45.9% | 0.05% | +57.6% |
| Q4 2020 | $475,000 | +77.9% | 4,577 | -18.7% | 0.03% | +37.5% |
| Q2 2020 | $267,000 | +17.1% | 5,632 | +8.6% | 0.02% | +33.3% |
| Q4 2019 | $228,000 | – | 5,187 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prossimo Advisors, LLC | 18,758 | $3,735 | 8.81% |
| Matisse Capital | 22,175 | $4,415,043 | 3.12% |
| Atika Capital Management LLC | 116,500 | $23,195,150 | 3.04% |
| APEIRON CAPITAL Ltd | 18,300 | $3,643,530 | 2.44% |
| AtonRa Partners | 4,374 | $870,863 | 1.83% |
| Rhenman & Partners Asset Management AB | 81,000 | $16,127,100 | 1.74% |
| GILDER GAGNON HOWE & CO LLC | 549,173 | $109,340,363 | 1.66% |
| Eversept Partners, LP | 84,462 | $16,816,384 | 1.42% |
| Biondo Investment Advisors, LLC | 37,451 | $7,456,394 | 1.40% |
| DEEPWATER ASSET MANAGEMENT, LLC | 15,321 | $3,050,411 | 1.40% |